BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11111295)

  • 1. [Vascularization of fibroadenomas: contrast harmonic imaging compared with contrast-enhanced power doppler].
    Huber S; Stiskal M; Steinbach R; Czembirek H
    Rofo; 2000 Oct; 172(10):830-5. PubMed ID: 11111295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US.
    Choi BI; Kim TK; Han JK; Kim AY; Seong CK; Park SJ
    Radiology; 2000 Feb; 214(2):381-6. PubMed ID: 10671584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced power Doppler harmonic imaging--influence on visualization of renal vasculature.
    Huber S; Steinbach R; Sommer O; Zuna I; Czembirek H; Delorme S
    Ultrasound Med Biol; 2000 Sep; 26(7):1109-15. PubMed ID: 11053745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US--early experience.
    Huber S; Helbich T; Kettenbach J; Dock W; Zuna I; Delorme S
    Radiology; 1998 Aug; 208(2):485-9. PubMed ID: 9680580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Color Doppler imaging of fibroadenomas of the breast with histopathologic correlation.
    Strano S; Gombos EC; Friedland O; Mozes M
    J Clin Ultrasound; 2004 Sep; 32(7):317-22. PubMed ID: 15293297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of vascularity in breast tumors--comparison of high frequency ultrasound and contrast-enhanced color harmonic imaging].
    Schröder RJ; Bostanjoglo M; Hidajat N; Rademaker J; Röttgen R; Mäurer J; Felix R
    Rofo; 2002 Sep; 174(9):1132-41. PubMed ID: 12221572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroadenomas: computer-assisted quantitative evaluation of contrast-enhanced power Doppler features and correlation with histopathology.
    Huber S; Vesely M; Zuna I; Delorme S; Czembirek H
    Ultrasound Med Biol; 2001 Jan; 27(1):3-11. PubMed ID: 11295265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonpalpable breast lesions: evaluation with power Doppler US and a microbubble contrast agent-initial experience.
    Moon WK; Im JG; Noh DY; Han MC
    Radiology; 2000 Oct; 217(1):240-6. PubMed ID: 11012451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative power Doppler ultrasonography with a contrast-enhancing agent for intracranial tumors.
    Kanno H; Ozawa Y; Sakata K; Sato H; Tanabe Y; Shimizu N; Yamamoto I
    J Neurosurg; 2005 Feb; 102(2):295-301. PubMed ID: 15739558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast enhanced harmonic ultrasound for differentiating breast tumors - first results.
    Jung EM; Jungius KP; Rupp N; Gallegos M; Ritter G; Lenhart M; Clevert DA; Kubale R
    Clin Hemorheol Microcirc; 2005; 33(2):109-20. PubMed ID: 16151258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor vascularization in experimental melanomas: correlation between unenhanced and contrast enhanced power Doppler imaging and histological grading.
    Schroeder RJ; Hauff P; Bartels T; Vogel K; Jeschke J; Hidajat N; Maeurer J
    Ultrasound Med Biol; 2001 Jun; 27(6):761-71. PubMed ID: 11516536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of signal-enhanced color Doppler ultrasound in space-occupying lesions of the skin and skin appendages].
    Schröder RJ; Mäurer J; Hidajat N; Zlowodski M; Schlums D; Weber S; Hosten N; Felix R
    Rofo; 1999 Sep; 171(3):211-8. PubMed ID: 10520331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ultrasonography contrast media Levovist and power Doppler in the study of the breast. Methodology, vascular morphology and automatic enhancement quantification with wash-in and wash-out curves].
    Menna S; Di Virgilio MR; Burke P
    Radiol Med; 1999 Jun; 97(6):472-8. PubMed ID: 10478204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma: power Doppler US with a contrast agent--preliminary results.
    Kim AY; Choi BI; Kim TK; Han JK; Yun EJ; Lee KY; Han MC
    Radiology; 1998 Oct; 209(1):135-40. PubMed ID: 9769824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound characteristics of breast fibroadenomas are related to clinical and histological parameters.
    Földi M; Klar M; Orlowska-Volk M; Hanjalic-Beck A; Osterloh B; Stickeler E; Watermann D
    Ultraschall Med; 2010 Oct; 31(5):475-83. PubMed ID: 19544233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive carcinomas and fibroadenomas of the breast: comparison of microvessel distributions--implications for imaging modalities.
    Weind KL; Maier CF; Rutt BK; Moussa M
    Radiology; 1998 Aug; 208(2):477-83. PubMed ID: 9680579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging.
    Wen YL; Kudo M; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
    J Med Ultrason (2001); 2003 Sep; 30(3):141-51. PubMed ID: 27278304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynamic assessment of contrast medium enhancement in Doppler ultrasound imaging. Current status].
    Huber S; Delorme S; Zuna I
    Radiologe; 1998 May; 38(5):390-3. PubMed ID: 9646345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase inversion harmonic imaging versus contrast-enhanced power Doppler sonography for the characterization of focal liver lesions.
    Strobel D; Raeker S; Martus P; Hahn EG; Becker D
    Int J Colorectal Dis; 2003 Jan; 18(1):63-72. PubMed ID: 12458384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of benign versus malignant breast disease.
    Ellis RL
    Radiology; 1999 Mar; 210(3):878-80. PubMed ID: 10207498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.